Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLFY
2651
DELISTED
Blue Foundry Bancorp
BLFY
| $733K | ﹤0.01% |
74,700
-11,600
| -13% | -$121K |
|
|
LENZ
2652
LENZ Therapeutics
LENZ
$148M
| $732K | ﹤0.01% |
25,366
-23,900
| -49% | -$729K |
|
2653
Vinci Compass Investments Ltd
VINP
$625M
| $729K | ﹤0.01% |
72,432
-9,100
| -11% | -$93.2K |
|
2654
World Kinect Corp
WKC
$1.87B
| $729K | ﹤0.01% |
26,500
-40,800
| -61% | -$1.17M |
|
2655
Reading International Class A
RDI
$37M
| $729K | ﹤0.01% |
552,190
-8,400
| -1% | -$12.4K |
|
|
GDEN
2656
DELISTED
Golden Entertainment
GDEN
| $729K | ﹤0.01% |
+23,062
| New | +$732K |
|
2657
Eastern Bankshares
EBC
$5.4B
| $729K | ﹤0.01% |
42,234
-83,900
| -67% | -$1.47M |
|
2658
VirTra
VTSI
$35.7M
| $728K | ﹤0.01% |
107,795
-15,505
| -13% | -$105K |
|
|
INVX
2659
Innovex International
INVX
$2.2B
| $727K | ﹤0.01% |
52,059
-24,700
| -32% | -$370K |
|
2660
Williams Companies
WMB
$90.5B
| $725K | ﹤0.01% |
13,391
-25,509
| -66% | -$1.37M |
|
|
NOAH
2661
Noah Holdings
NOAH
$588M
| $725K | ﹤0.01% |
61,882
-63,733
| -51% | -$789K |
|
2662
Biohaven
BHVN
$2.2B
| $723K | ﹤0.01% |
+19,352
| New | +$903K |
|
2663
CuriosityStream
CURI
$218M
| $720K | ﹤0.01% |
470,900
+41,454
| +10% | +$79.9K |
|
2664
Senseonics Holdings Inc
SENS
$415M
| $720K | ﹤0.01% |
+68,801
| New | +$492K |
|
|
VRNA
2665
DELISTED
Verona Pharma
VRNA
| $720K | ﹤0.01% |
+15,500
| New | +$582K |
|
|
KYNB
2666
Kyntra Bio
KYNB
$29.5M
| $719K | ﹤0.01% |
54,348
+24,222
| +80% | +$225K |
|
2667
Park-Ohio Holdings
PKOH
$701M
| $717K | ﹤0.01% |
27,300
+19,410
| +246% | +$584K |
|
2668
DT Midstream
DTM
$13.8B
| $716K | ﹤0.01% |
7,200
-12,600
| -64% | -$1.2M |
|
|
TUYA
2669
Tuya Inc
TUYA
$1.1B
| $714K | ﹤0.01% |
399,100
| – | – |
|
2670
Vanguard Materials ETF
VAW
$3.07B
| $714K | ﹤0.01% |
3,800
+1,000
| +36% | +$206K |
|
2671
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $713K | ﹤0.01% |
5,400
-1,800
| -25% | -$251K |
|
|
NUVL
2672
DELISTED
Nuvalent
NUVL
| $712K | ﹤0.01% |
+9,100
| New | +$850K |
|
2673
Destination XL Group
DXLG
$35.4M
| $712K | ﹤0.01% |
264,500
-36,800
| -12% | -$98.8K |
|
2674
ACNB Corp
ACNB
$655M
| $711K | ﹤0.01% |
17,856
-500
| -3% | -$22.2K |
|
2675
WisdomTree US MidCap Dividend Fund
DON
$4.13B
| $708K | ﹤0.01% |
+13,900
| New | +$729K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.